CRISPR gene-editing technology has emerged as a promising tool to tackle genetic diseases. It was first used for therapy in 2020 to treat patients with sickle cell disease and beta-thalassemia, and now it is being used for conditions including cancer, AIDS, cystic fibrosis, muscular dystrophy, Huntington’s disease, blood disorders, and even COVID-19. However, due to potential risks and limitations, further research and careful monitoring are needed to enhance the safety and efficacy of CRISPR therapies.
Kowloon East Cluster April 05: 56k Patient Data Leak Spurs Cyber Spend – Meyka
Kowloon East Cluster April 05: 56k Patient Data Leak Spurs Cyber Spend Meyka
